Literature DB >> 33847933

Functional Hemolytic Test for Complement Alternative Pathway Convertase Activity.

Elena B Volokhina1,2, Bert L P W J van den Heuvel3,4,5,6, Marloes A H M Michels1, Nicole C A J van de Kar1.   

Abstract

The complement system is a key part of innate immunity. However, if the system becomes dysregulated, damage to healthy host cells can occur, especially to the glomerular cells of the kidney. The convertases of the alternative pathway of the complement system play a crucial role in complement activation. In healthy conditions, their activity is strictly regulated. In patients with diseases caused by complement alternative pathway dysregulation, such as C3 glomerulopathy and atypical hemolytic uremic syndrome, factors can be present in the blood that disturb this delicate balance, leading to convertase overactivity. Such factors include C3 nephritic factors, which are autoantibodies against the C3 convertase that prolong its activity, or genetic variants resulting in a stabilized convertase complex. This chapter describes a method in which the activity and stability of the alternative pathway convertases can be measured to detect aberrant serum factors causing convertase overactivity.

Entities:  

Keywords:  Alternative pathway; Atypical hemolytic uremic syndrome; C3 glomerulopathy; C3 nephritic factor; Complement; Convertase; Eculizumab; Hemolytic assay; Mutation; Rabbit erythrocytes

Year:  2021        PMID: 33847933     DOI: 10.1007/978-1-0716-1016-9_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  24 in total

1.  The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation.

Authors:  M Harboe; G Ulvund; L Vien; M Fung; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

Review 2.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

Review 3.  Complement driven by conformational changes.

Authors:  Piet Gros; Fin J Milder; Bert J C Janssen
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

Review 4.  The membrane attack complex as an inflammatory trigger.

Authors:  B Paul Morgan
Journal:  Immunobiology       Date:  2015-04-30       Impact factor: 3.144

Review 5.  Protection of host cells by complement regulators.

Authors:  Christoph Q Schmidt; John D Lambris; Daniel Ricklin
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

6.  The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification.

Authors:  Morten Harboe; Peter Garred; Ellen Karlstrøm; Julie K Lindstad; Gregory L Stahl; Tom Eirik Mollnes
Journal:  Mol Immunol       Date:  2009-10-01       Impact factor: 4.407

Review 7.  Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  Am J Kidney Dis       Date:  2015-05-29       Impact factor: 8.860

Review 8.  Complement System Part I - Molecular Mechanisms of Activation and Regulation.

Authors:  Nicolas S Merle; Sarah Elizabeth Church; Veronique Fremeaux-Bacchi; Lubka T Roumenina
Journal:  Front Immunol       Date:  2015-06-02       Impact factor: 7.561

9.  Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode.

Authors:  Federico Forneris; Jin Wu; Xiaoguang Xue; Daniel Ricklin; Zhuoer Lin; Georgia Sfyroera; Apostolia Tzekou; Elena Volokhina; Joke Cm Granneman; Richard Hauhart; Paula Bertram; M Kathryn Liszewski; John P Atkinson; John D Lambris; Piet Gros
Journal:  EMBO J       Date:  2016-03-24       Impact factor: 11.598

10.  Molecular insights into the surface-specific arrangement of complement C5 convertase enzymes.

Authors:  Evelien T M Berends; Ronald D Gorham; Maartje Ruyken; Jasper A Soppe; Hatice Orhan; Piet C Aerts; Carla J C de Haas; Piet Gros; Suzan H M Rooijakkers
Journal:  BMC Biol       Date:  2015-11-09       Impact factor: 7.431

View more
  1 in total

1.  Different Aspects of Classical Pathway Overactivation in Patients With C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis.

Authors:  Marloes A H M Michels; Nicole C A J van de Kar; Sanne A W van Kraaij; Sebastian A Sarlea; Valentina Gracchi; Flore A P T Engels; Eiske M Dorresteijn; Johannes van der Deure; Caroline Duineveld; Jack F M Wetzels; Lambertus P W J van den Heuvel; Elena B Volokhina
Journal:  Front Immunol       Date:  2021-08-11       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.